ESMO scientific and educational resources on this topic
Recent medwireNews, books and resources from conferences are for ESMO Members only.
Tumour Sites: Central Nervous System Malignancies
Neuro-Oncology
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
INDIGO Supports Vorasidenib For IDH-Mutant Grade 2 Diffuse Glioma
BRAF–MEK Inhibition May Offer ‘Notable Activity’ Against BRAF-Mutated Glioma
Adjuvant Temozolomide Benefit Confirmed For 1p/19q Non-Co-Deleted Anaplastic Glioma
E-Learning
ESMO E-Learning: Multidisciplinary Treatment of Glioblastoma
ESMO E-Learning: Management of Patients with Brain Metastases: Focusing on Radiotherapy
Factsheets on Biomarkers
TERT Mutations in Glioma: ESMO Biomarker Factsheet
MGMT Promoter Methylation in Glioma: ESMO Biomarker Factsheet
IDH1/2 Mutations in Glioma: ESMO Biomarker Factsheet
1p/19q Co-deletion in Glioma: ESMO Biomarker Factsheet
Meeting resources
CNS tumours
Presenter: Anna Sophie Berghoff
Session: Scientific Congress Highlights 1
Resources:
Slides
Webcast
Break
Presenter: Fabrice André
Session: Scientific Congress Highlights 1
Resources:
Webcast
Upfront and salvage surgery for low grade gliomas: Do tumour mutations need different strategies?
Presenter: Asgeir Jakola
Session: Challenging common problems in neuro-oncology
Resources:
Slides
Webcast
Radiotherapy for low grade gliomas with and without mutations: Wait or treat?
Presenter: Helen Shih
Session: Challenging common problems in neuro-oncology
Resources:
Slides
Webcast
The optimal radiochemotherapeutic combination for low grade gliomas: Lessons from trials
Presenter: Enrico Franceschi
Session: Challenging common problems in neuro-oncology
Resources:
Slides
Webcast